Education
About Us
Working with TipRanks
Follow Us
Cencora (COR)
NYSE:COR
COR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$218.65 - $309.35
Previous CloseN/A
Volume440.68K
Average Volume (3M)1.10M
Market Cap
$56.36B
Enterprise Value$64.73B
Total Cash (Recent Filing)$2.23B
Total Debt (Recent Filing)$8.24B
Price to Earnings (P/E)29.9
Beta0.13
Next Earnings
Nov 06, 2025EPS Estimate
3.81Next Dividend Ex-Date
Aug 15, 2025Dividend Yield0.75%
Share Statistics
EPS (TTM)4.00
Shares Outstanding193,877,880
10 Day Avg. Volume1,282,361
30 Day Avg. Volume1,096,324
Financial Highlights & Ratios
PEG Ratio-2.50
Price to Book (P/B)69.17
Price to Sales (P/S)0.15
P/FCF Ratio14.91
Enterprise Value/Market Cap1.15
Enterprise Value/Revenue0.20
Enterprise Value/Gross Profit5.88
Enterprise Value/Ebitda14.46
Forecast
1Y Price Target
$334.10Price Target Upside15.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Bulls Say, Bears Say
Bulls Say
Financial PerformanceManagement raised its full-year adjusted EPS guidance, indicating confidence in future performance.
Market PositionCOR's core pharma business continues to outperform driven by strong fundamentals and healthy utilization.
ValuationThe improvement in valuation is justified by a strong industry backdrop and relatively low exposure to macro and policy risks.
Bears Say
Earnings RiskThe loss of FCS and Publix could impact future earnings, despite overall positive growth estimates.
International OperationsSoftness on the International side created a mathematical shortfall for the segment.
Cencora News
COR FAQ
What was Cencora’s price range in the past 12 months?
Cencora lowest stock price was $218.65 and its highest was $309.35 in the past 12 months.
What is Cencora’s market cap?
Cencora’s market cap is $56.36B.
When is Cencora’s upcoming earnings report date?
Cencora’s upcoming earnings report date is Nov 06, 2025 which is in 84 days.
How were Cencora’s earnings last quarter?
Cencora released its earnings results on Aug 06, 2025. The company reported $4 earnings per share for the quarter, beating the consensus estimate of $3.848 by $0.152.
Is Cencora overvalued?
According to Wall Street analysts Cencora’s price is currently Undervalued.
Does Cencora pay dividends?
Cencora pays a Quarterly dividend of $0.55 which represents an annual dividend yield of 0.75%. See more information on Cencora dividends here
What is Cencora’s EPS estimate?
Cencora’s EPS estimate is 3.81.
How many shares outstanding does Cencora have?
Cencora has 193,877,880 shares outstanding.
What happened to Cencora’s price movement after its last earnings report?
Cencora reported an EPS of $4 in its last earnings report, beating expectations of $3.848. Following the earnings report the stock price went down -2.931%.
Which hedge fund is a major shareholder of Cencora?
Currently, no hedge funds are holding shares in COR
Cencora Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$334.10 (15.55% Upside)
$334.10 (15.55% Upside)
Blogger Sentiment
Bullish
COR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 883.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.6%
Last 30 Days ▲ 3.4%
Last 30 Days ▲ 3.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.39%
12-Months-Change
Fundamentals
Return on Equity
130.60%
Trailing 12-Months
Asset Growth
10.76%
Trailing 12-Months
Company Description
Cencora
Cencora (COR) is a global leader in the pharmaceutical supply chain, specializing in providing comprehensive services for the healthcare and life sciences sectors. The company operates in various segments, including logistics, distribution, and regulatory compliance, offering a suite of products and services designed to ensure the efficient delivery of pharmaceuticals and medical devices. Cencora focuses on enhancing supply chain performance for pharmaceutical manufacturers, healthcare providers, and patients through innovative solutions and robust infrastructure.
COR Company Deck
COR Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Cencora delivered strong financial results with significant growth in operating income and EPS, particularly in the U.S. Healthcare Solutions segment. However, challenges in the International Healthcare Solutions segment and moderated growth in GLP-1 sales present some concerns. The raised fiscal 2025 guidance and specialty market leadership are positive indicators, suggesting a generally favorable outlook.View all COR earnings summariesCOR Revenue Breakdown
89.54% U.S. Healthcare Solutions
10.46% International Healthcare Solutions
COR Stock 12 Month Forecast
Average Price Target
$334.10
▲(15.55% Upside)
Technical Analysis
Ownership Overview
6.79% Insiders
27.70% Mutual Funds
1.27% Other Institutional Investors
38.75% Public Companies and Individual Investors
Options Prices
Currently, No data available
---